CD14hiHLA-DRdim macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease

The increase of CD14+ lamina propria macrophages in active Crohnˈs disease is due to a subset discriminated by HLA‐DR, likely from CD16− blood monocytes. Intestinal Mϕ play an important role in maintaining gut homeostasis. However, little is known about these cells, their precursors, and their role...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of leukocyte biology 2014-03, Vol.95 (3), p.531-541
Hauptverfasser: Thiesen, Susanne, Janciauskiene, Sabina, Uronen‐Hansson, Heli, Agace, William, Högerkorp, Carl‐Magnus, Spee, Pieter, Håkansson, Katarina, Grip, Olof
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The increase of CD14+ lamina propria macrophages in active Crohnˈs disease is due to a subset discriminated by HLA‐DR, likely from CD16− blood monocytes. Intestinal Mϕ play an important role in maintaining gut homeostasis. However, little is known about these cells, their precursors, and their role in intestinal inflammation. Here, we characterize the CD14+ mononuclear cell populations in intestinal mucosa and blood in patients with CD. Among the LP CD14+ Mϕ, we identified three distinct HLA‐DR+‐expressing subsets. Compared with uninflamed, inflamed mucosa contained a marked increase in the proportion of the CD14hiHLA‐DRdim cellular subset. This subset resembled the classical blood monocytes with low CD16, HLA‐DR, and CX3CR1 expression. Classical monocytes migrated efficiently toward CCL2 and released the highest levels of MMP‐1 and proinflammatory cytokines when stimulated with immune complexes or LPS. Our findings strongly suggest that it is the classical and not the intermediate or nonclassical monocytes that are the precursors to the dominating intestinal CD14hiHLA‐DRdim subset. This enhances our understanding of CD pathology and may provide new options in treatment.
ISSN:0741-5400
1938-3673
DOI:10.1189/jlb.0113021